-
A Breakthrough for Narcolepsy Type 1: FDA Approves Orzeyful (oveporexton)
NYSE: $TAK A New Frontier in Narcolepsy Treatment For individuals living with Narcolepsy Type 1, daily life can be a constant battle against excessive daytime sleepiness and cataplexy. Recently, there has been a significant milestone in sleep medicine: the FDA has officially approved Orzeyful (oveporexton) as a targeted treatment for the underlying cause of this…